• Investor Growth Capital Europe is no longer seeking new companies to invest in, but will focus on developing the companies where we are already owners.
• We strive to reach the maximum return on our investments through growing the companies we are owners in.

We are a committed investor with a long-term investment philosophy, staying power and value-creating agendas. We always work closely with the management of our holdings to develop their growth strategy, business and organization.

Our holdings directly benefit from the experience and analytical skills of our investment professionals and the technical and managerial expertise of our senior advisers.

The current portfolio primarily consists of Nordic Today, we primarily invest in expansion-stage companies in the life sciences and technology fields.

We have invested in companies with innovative technologies and products, and with a scalable business model offering a sustainable competitive advantage.

Investor Growth Capital Europe companies typically have proven market potential and some level of established customer base or clinical evidence. They are driven by strong and highly motivated management teams working in strategic partnership with us.

Investment sectors

Our investment candidates are typically found within the following subsectors:

Life Sciences

• Medical devices
• Pharmaceuticals and bioceuticals
• Diagnostics
• Healthcare services and life science tools

Technology

• Software and online
• Telecom and datacom equipment
• Clean technologies
• Disruptive technologies